1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2023
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
(
- Contribution to journal › Article
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
(
- Contribution to journal › Article
-
Mark
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction : The Perfect-CR study
(
- Contribution to journal › Article
- 2022
-
Mark
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Effect of a Lifestyle-Focused Web-Based Application on Risk Factor Management in Patients Who Have Had a Myocardial Infarction : Randomized Controlled Trial
(
- Contribution to journal › Article
- 2021
-
Mark
Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation
(
- Contribution to journal › Article